Annexin A5-arkiv - BioStock

Annexin framgång RVO

Annexin’s CEO: “Our biggest success in a long time”

5 September, 2023

Annexin imagingdata

Annexin’s CMO on study results and participation in ARVO

12 May, 2023

Annexin Q4 2022

Intense Q4 leads Annexin into interesting 2023

16 February, 2023

Annexin Q3 2022

Annexin updates in conjunction with the Q3 report

10 November, 2022

Phase II focus and further potential in Annexin´s Q2

31 August, 2022

Annexin Pharmaceuticals

Annexin´s CMO on patent strategy

19 May, 2022

FDA

Annexin receives FDA approval for phase II study

8 April, 2022